BlackRock Health Sciences Trust (BME) to Issue Monthly Dividend of $0.26 on October 30th

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Thursday, September 10th. Stockholders of record on Thursday, October 15th will be paid a dividend of 0.2621 per share on Friday, October 30th. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. The ex-dividend date of this dividend is Thursday, October 15th.

BlackRock Health Sciences Trust Price Performance

NYSE BME opened at $44.26 on Friday. The stock’s fifty day moving average price is $44.20 and its 200 day moving average price is $41.51. BlackRock Health Sciences Trust has a 1 year low of $35.95 and a 1 year high of $46.42.

Institutional Trading of BlackRock Health Sciences Trust

Several large investors have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its stake in shares of BlackRock Health Sciences Trust by 285,436.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock worth $166,414,000 after purchasing an additional 4,044,638 shares during the last quarter. Bank of America Corp DE purchased a new stake in BlackRock Health Sciences Trust in the second quarter valued at approximately $11,827,000. 1607 Capital Partners LLC increased its holdings in BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock worth $9,429,000 after buying an additional 75,958 shares during the period. Invesco Ltd. increased its holdings in BlackRock Health Sciences Trust by 7.6% in the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after buying an additional 15,381 shares during the period. Finally, Royal Bank of Canada increased its holdings in BlackRock Health Sciences Trust by 13.0% in the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock worth $6,600,000 after buying an additional 18,442 shares during the period.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.